Immunohistochemical detection of complement factors: a reliable method for the diagnosis of myasthenia gravis

被引:0
|
作者
Zander, T
Schwab, S
Laufenberg, I
Sieb, JP
机构
[1] Univ Bonn, Neurol Kliniken, D-5300 Bonn, Germany
[2] Heidelberg Univ, Neurol Kliniken, D-6900 Heidelberg, Germany
来源
NERVENARZT | 2000年 / 71卷 / 08期
关键词
myasthenia gravis; diagnosis; complement; neuromuscular junction;
D O I
10.1007/s001150050644
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 57-year-old woman suffered from generalized muscular weakness without diplopia or dysphagia for about 2 years. An abnormal decremental response on low frequency nerve stimulation and improvement upon administration of edrophonium chloride suggested a diagnosis of myasthenia gravis. However,this diagnosis remained uncertain, since repeated tests for antiacetylcholine receptor antibodies were negative. In addition, the patient reported that she was never able to keep up with peers in prolonged physical activities since childhood. For this reason, a congenital myasthenic syndrome was suspected and an intercostal muscle biopsy performed for special end-plate studies. Immunohistochemistry of the muscle biopsy revealed membrane attack complex deposits at the end-plates. This finding definitely confirmed the diagnosis of autoimmune myasthenia gravis. In conclusion, immunohistochemistry for complement deposits at the end-plates is a simple and reliable method of confirming the diagnosis of myasthenia gravis in uncertain cases.
引用
收藏
页码:666 / 669
页数:4
相关论文
共 50 条
  • [1] Immunohistochemical detection of complement factors: A reliable method for the diagnosis of myasthenia gravis [Immunhistochemischer komplementnachweis: Eine einfache methode zur sicherung einer Myasthenia-gravis-diagnose]
    Zander T.
    Schwab S.
    Laufenberg I.
    Sieb J.P.
    Der Nervenarzt, 2000, 71 (8) : 666 - 669
  • [2] Complement and myasthenia gravis
    Sanderson, Nicholas S. R.
    MOLECULAR IMMUNOLOGY, 2022, 151 : 11 - 18
  • [3] Role of complement in myasthenia gravis
    San, Pyae Phyo
    Jacob, Saiju
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [4] Myasthenia gravis: the role of complement at the neuromuscular junction
    Howard, James F., Jr.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1412 (01) : 113 - 128
  • [5] Complement associated pathogenic mechanisms in myasthenia gravis
    Tuzun, Erdem
    Christadoss, Premkumar
    AUTOIMMUNITY REVIEWS, 2013, 12 (09) : 904 - 911
  • [6] Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis
    Kaminski, HJ
    Li, ZY
    Richmonds, C
    Lin, F
    Medof, ME
    EXPERIMENTAL NEUROLOGY, 2004, 189 (02) : 333 - 342
  • [7] The role of complement in experimental autoimmune myasthenia gravis
    Kusner, Linda L.
    Kaminski, Henry J.
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 127 - 132
  • [8] Targeting complement system to treat myasthenia gravis
    Huda, Ruksana
    Tuzun, Erdem
    Christadoss, Premkumar
    REVIEWS IN THE NEUROSCIENCES, 2014, 25 (04) : 575 - 583
  • [9] COMPLEMENT INHIBITION IN MYASTHENIA GRAVIS: A TRANSFORMATIVE THERAPY
    Howard, James F., Jr.
    MUSCLE & NERVE, 2019, 60 : S1 - S1
  • [10] Factors affecting the diagnostic delay of myasthenia gravis
    Marlet, I. R.
    Andersen, R. K.
    Axelsen, K. H.
    Andersen, L. K.
    Vissing, J.
    Witting, N.
    JOURNAL OF NEUROLOGY, 2025, 272 (01)